# A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers

> **NCT00608699** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Healthy Subjects
- Dyslipidaemias

## Interventions

- **DRUG:** GSK256073A tablets + IR niacin tablets

## Key facts

- **NCT ID:** NCT00608699
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00608699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00608699, "A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00608699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*